BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
3.5
Last period Current ratio
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
BioNexus Gene`s Current ratio for the last twelve months ended 2023-09-30 is 3.5
